{
    "id": "cd161a2fd6",
    "abstract": [],
    "body_text": [
        {
            "text": "Colorectal cancer (CRC) is the second most prevalent cancer in the Netherlands. "
        },
        {
            "text": "There were about 45 000 CRC survivors in 2000, while in 2020 the total number is expected to have doubled [1]. ",
            "ref_spans": [
                {
                    "start": 106,
                    "end": 109,
                    "type": "bibr",
                    "text": "[1]"
                }
            ]
        },
        {
            "text": "Most research among CRC survivors focusses on the role of clinical variables, like diagnosis and treatment, on healthrelated quality of life (HRQoL) and disease-specific health status (e.g. side effects and symptoms). "
        },
        {
            "text": "However, the role of individual differences in this matter is under exposed. "
        },
        {
            "text": "The holy grail of personalized medicine, which is currently the dominant ambition of translational research, will remain elusive unless we can find ways to identify those patients that experience a healthy cancer survivorship, and those patients who do not. "
        },
        {
            "text": "In addition to clinical and demographic characteristics, individual differences in personality can probably help to identify those patients [2].",
            "ref_spans": [
                {
                    "start": 140,
                    "end": 143,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[2]"
                }
            ]
        },
        {
            "text": "Type D personality has been shown to be an important predictor of HRQoL and disease-specific health status in medical and general populations, above and Acta Oncologica, 2015;54: 669-677 beyond clinical characteristics [3][4][5]. ",
            "ref_spans": [
                {
                    "start": 158,
                    "end": 175,
                    "type": "bibr",
                    "text": "Oncologica, 2015;"
                },
                {
                    "start": 175,
                    "end": 186,
                    "type": "bibr",
                    "text": "54: 669-677"
                },
                {
                    "start": 219,
                    "end": 222,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "[3]"
                },
                {
                    "start": 222,
                    "end": 225,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "[4]"
                },
                {
                    "start": 225,
                    "end": 228,
                    "type": "bibr",
                    "text": "[5]"
                }
            ]
        },
        {
            "text": "Type D is defined by the combination of two personality traits; the tendency to experience negative emotions [negative affectivity (Na)] and to inhibit self-expression in social interaction [social inhibition (SI)] [6]. ",
            "ref_spans": [
                {
                    "start": 190,
                    "end": 213,
                    "type": "bibr",
                    "text": "[social inhibition (SI)"
                },
                {
                    "start": 215,
                    "end": 218,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[6]"
                }
            ]
        },
        {
            "text": "as such, Type D has been associated with adverse health outcomes, impaired health status and HRQoL, more serious illness perceptions and an increased health care utilization [2,4,5,7,8]. ",
            "ref_spans": [
                {
                    "start": 174,
                    "end": 177,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "[2,"
                },
                {
                    "start": 177,
                    "end": 179,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "4,"
                },
                {
                    "start": 179,
                    "end": 181,
                    "type": "bibr",
                    "text": "5,"
                },
                {
                    "start": 181,
                    "end": 183,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "7,"
                },
                {
                    "start": 183,
                    "end": 185,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "8]"
                }
            ]
        },
        {
            "text": "Overall, the Na component of Type D plays a more important role than the SI component in terms of general HRQoL, while the specific combination of Na and SI in Type D has been related to symptoms of anhedonia, mental fatigue and decreased motivation [9]. ",
            "ref_spans": [
                {
                    "start": 250,
                    "end": 253,
                    "type": "bibr",
                    "ref_id": "b14",
                    "text": "[9]"
                }
            ]
        },
        {
            "text": "There are a number of potential pathways that could explain the relationship between personality and worse self-reported health and HRQoL. "
        },
        {
            "text": "For example, patients with Type D and high Na may be more likely to perceive and attend to somatic symptoms and to interpret them as potentially pathological [8]. ",
            "ref_spans": [
                {
                    "start": 158,
                    "end": 161,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[8]"
                }
            ]
        },
        {
            "text": "In addition, Type D personality has been associated with an unhealthy lifestyle and poor treatment adherence, which, in turn, may have an adverse effect on perceived health [8].",
            "ref_spans": [
                {
                    "start": 173,
                    "end": 176,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[8]"
                }
            ]
        },
        {
            "text": "Research on the association of personality and HRQoL among CRC cancer patients is scarce but rising. "
        },
        {
            "text": "a recent cross-sectional study among 162 CRC patients reported that personality was associated with HRQoL, independent of disease severity and psychological distress [10]. ",
            "ref_spans": [
                {
                    "start": 166,
                    "end": 170,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "[10]"
                }
            ]
        },
        {
            "text": "Furthermore, a prospective study among 144 CRC patients stated that personality variables can predict a decrease in HRQoL over a oneyear period [11]. ",
            "ref_spans": [
                {
                    "start": 144,
                    "end": 148,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "[11]"
                }
            ]
        },
        {
            "text": "also, Type D personality was associated with poor quality of life and mental health among CRC and other cancer survivors in a crosssectional population-based study (n \ue035 3080) [7]. ",
            "ref_spans": [
                {
                    "start": 175,
                    "end": 178,
                    "type": "bibr",
                    "ref_id": "b11",
                    "text": "[7]"
                }
            ]
        },
        {
            "text": "a recent review stated that \"more well-designed prospective investigations are necessary to establish the contributory role of personality dimensions for the development of and protection from distress and impairment in the HRQoL of CRC patients\" [8]. ",
            "ref_spans": [
                {
                    "start": 247,
                    "end": 250,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "[8]"
                }
            ]
        },
        {
            "text": "In order to predict which CRC patients will experience a self-reported healthy cancer survivorship, we will investigate the degree to which HRQoL and disease-specific health status can be explained by individual differences in the personality (e.g. Na, SI and Type D personality), while controlling for clinical characteristics."
        },
        {
            "text": "Data from the first three waves (2010, 2011 and 2012) of a prospective population-based yearly survey among CRC survivors from the Eindhoven Cancer Registry (ECR) was used. ",
            "section": "Setting and participants"
        },
        {
            "text": "The ECR compiles data of all individuals newly diagnosed with cancer in the southern part of the Netherlands, an area with 10 hospitals serving 2.3 million inhabitants [12]. ",
            "section": "Setting and participants",
            "ref_spans": [
                {
                    "start": 168,
                    "end": 172,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "[12]"
                }
            ]
        },
        {
            "text": "Everyone diagnosed with CRC from 2000 to 2009 as registered in the ECR was eligible for participation. ",
            "section": "Setting and participants"
        },
        {
            "text": "Those with unverifiable addresses, with cognitive impairment, who died prior to the start of study or were terminally ill, with stage 0/carcinoma in situ, and those already included in our 2009 study or another study (n \ue035 169) were excluded. ",
            "section": "Setting and participants"
        },
        {
            "text": "a complete overview of the selection of patients can be found on our website http://www.profilesregistry.nl/ dataarchive/study_units/view/22 under 'data & documentation'. ",
            "section": "Setting and participants"
        },
        {
            "text": "This study was approved by the certified Medical Ethics Committee of the Maxima Medical Centre, Veldhoven, The Netherlands.",
            "section": "Setting and participants"
        },
        {
            "text": "Data collection was done within PROFILES [13]. ",
            "section": "Setting and participants",
            "ref_spans": [
                {
                    "start": 41,
                    "end": 45,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "[13]"
                }
            ]
        },
        {
            "text": "Data from the PROFILES registry is freely available for non-commercial scientific research, subject to study question, privacy and confidentiality restrictions, and registration (www.profilesregistry.nl).",
            "section": "Setting and participants"
        },
        {
            "text": "Survivors were informed of the study via a letter from their (ex-)attending specialist. ",
            "section": "Data collection"
        },
        {
            "text": "The letter included a link to a secure website, a login name, and a password, so that interested patients could provide informed consent and complete questionnaires online. ",
            "section": "Data collection"
        },
        {
            "text": "If the patient preferred written rather than digital communication, (s)he could return our postcard by mail after which (s)he received our paperand-pencil informed consent form and questionnaire. ",
            "section": "Data collection"
        },
        {
            "text": "Non-respondents were sent a reminder letter and paper-and-pencil questionnaire within two months.",
            "section": "Data collection"
        },
        {
            "text": "Survivors' sociodemographic and clinical information were available from the ECR. ",
            "section": "Data collection"
        },
        {
            "text": "Comorbidity at the time of the study was assessed with the adapted Selfadministered Comorbidity Questionnaire [14]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 110,
                    "end": 114,
                    "type": "bibr",
                    "text": "[14]"
                }
            ]
        },
        {
            "text": "Questions on marital status, educational level, and current occupation were included in the questionnaire.",
            "section": "Data collection"
        },
        {
            "text": "NA, SI and Type D personality. ",
            "section": "Data collection"
        },
        {
            "text": "Na, SI, and the Type D personality construct were assessed with the Type D Personality Scale (DS14) [6]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 100,
                    "end": 103,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[6]"
                }
            ]
        },
        {
            "text": "The 14 items are answered on a five-point response scale ranging from 0 (false) to 4 (true). ",
            "section": "Data collection"
        },
        {
            "text": "The DS14 has good measurement properties; the subscales have high reliability (Cronbach's alpha 0.88/0.86) and good test-retest reliability over a three-month period of r \ue035 0.72/0.82 for the two subscales, respectively, and the DS14 discriminates well between Type D and non-Type personality [6,15]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 292,
                    "end": 295,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[6,"
                },
                {
                    "start": 295,
                    "end": 298,
                    "type": "bibr",
                    "text": "15]"
                }
            ]
        },
        {
            "text": "To compare the separate and combined effects of high and low trait levels, the standard cut-off score \ue024 10 on the Na and SI subscales of the DS14 [6] was used to classify patients in four personality groups based on their scores at T1: Na \ue024 10 and SI \ue024 10 (Na\ue031/SI\ue031; the 'Type D' group), Na \ue024 10 but SI \ue023 9 (Na\ue031/SI-; the 'Na only' group), SI \ue024 10 but Na \ue023 9 (Na-/SI\ue031; the 'SI only' group), and both Na \ue023 9 and SI \ue023 9 (Na-/SI-; the 'reference' group).",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 146,
                    "end": 149,
                    "type": "bibr",
                    "ref_id": "b9",
                    "text": "[6]"
                }
            ]
        },
        {
            "text": "Quality of life. ",
            "section": "Data collection"
        },
        {
            "text": "The EORTC QLQ-C30 (Version 3.0) was used to assess cancer-specific QoL [16]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 71,
                    "end": 75,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "[16]"
                }
            ]
        },
        {
            "text": "It contains five functional scales, a global health status/ QoL scale, three symptoms scales, and six single items. ",
            "section": "Data collection"
        },
        {
            "text": "Each item is scored on a four-point Likertscale, except the global QoL scale, which has a sevenpoint Likert-scale. ",
            "section": "Data collection"
        },
        {
            "text": "Scores were linear transformed to a 0-100 scale [17]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 48,
                    "end": 52,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[17]"
                }
            ]
        },
        {
            "text": "a higher score on the functional scales and global QoL scale means better functioning and QoL. ",
            "section": "Data collection"
        },
        {
            "text": "a higher score on the symptom scales mean more complaints.",
            "section": "Data collection"
        },
        {
            "text": "Disease-specific health status. ",
            "section": "Data collection"
        },
        {
            "text": "Disease-specific health status was assessed with the EORTC QLQ-CR38 [18]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 68,
                    "end": 72,
                    "type": "bibr",
                    "text": "[18]"
                }
            ]
        },
        {
            "text": "It consists of two multi-item and two singleitem scales, seven symptom scales, and an item on weight loss. ",
            "section": "Data collection"
        },
        {
            "text": "Items were scored on a four-point Likert-scale. ",
            "section": "Data collection"
        },
        {
            "text": "all scales were linearly converted to a 0-100 scale. ",
            "section": "Data collection"
        },
        {
            "text": "a higher score on the EORTC QLQ-CR38 functional scales and single items (i.e. body image, sexual functioning, sexual enjoyment and future perspective) represent a higher level of function. ",
            "section": "Data collection"
        },
        {
            "text": "For the symptom scales and single items, a higher score represents a higher level of symptoms.",
            "section": "Data collection"
        },
        {
            "text": "Depression. ",
            "section": "Data collection"
        },
        {
            "text": "Depressive symptoms were assessed with the depression subscale of the Hospital anxiety and Depression Scale (HaDS) comprising of seven items on a four-point Likert-scale [19]. ",
            "section": "Data collection",
            "ref_spans": [
                {
                    "start": 170,
                    "end": 174,
                    "type": "bibr",
                    "text": "[19]"
                }
            ]
        },
        {
            "text": "It assesses levels of symptoms in the last week. ",
            "section": "Data collection"
        },
        {
            "text": "The scale mainly covers anhedonia and loss of interest, which are core depressive symptoms.",
            "section": "Data collection"
        },
        {
            "text": "Differences in sociodemographic and clinical characteristics between respondents, non-respondents or patients with unverifiable addresses at T1 and between patients who completed one or more questionnaires were compared with a c 2 , aNOVa or independent samples t-test where appropriate.",
            "section": "Statistical analyses"
        },
        {
            "text": "all other analyses are based on patients who completed at least two questionnaires. ",
            "section": "Statistical analyses"
        },
        {
            "text": "Differences in sociodemographic and clinical characteristics between patients with different personality types (Na-/SI-; Na-/SI\ue031; Na\ue031/SI-; Type D) were compared with a c 2 or aNOVa while differences in HRQoL and disease-specific health status were determined by aNOVas at each time point. ",
            "section": "Statistical analyses"
        },
        {
            "text": "as our results showed that Na had a large effect on our outcomes, the same analyses were performed for continuous Na scores divided into quartiles.",
            "section": "Statistical analyses"
        },
        {
            "text": "The course of HRQoL and disease-specific health status (separate models for each scale) according to the four personality groups was analyzed using linear mixed effects models (i.e. covariance pattern model with an unstructured error variance matrix and maximum likelihood estimation). ",
            "section": "Statistical analyses"
        },
        {
            "text": "This technique uses data efficiently by also including incomplete cases in the analyses. ",
            "section": "Statistical analyses"
        },
        {
            "text": "as a result of this, bias is limited and statistical power is preserved. ",
            "section": "Statistical analyses"
        },
        {
            "text": "Time was analyzed as a regular categorical predictor with three levels (i.e. three time points). ",
            "section": "Statistical analyses"
        },
        {
            "text": "Sex, age, time since diagnosis, treatment, disease stage, comorbid conditions, partnership and educational level and depression levels were entered as covariates into the models, based on a priori assumptions/hypotheses. ",
            "section": "Statistical analyses"
        },
        {
            "text": "Sociodemographic and clinical characteristics were analyzed as timeinvariant predictors (i.e. baseline characteristics were used). ",
            "section": "Statistical analyses"
        },
        {
            "text": "Depression scores were analyzed as continuous time varying predictors. ",
            "section": "Statistical analyses"
        },
        {
            "text": "In order to correctly interpret all model parameters, all continuous variables have been grand-mean centered.",
            "section": "Statistical analyses"
        },
        {
            "text": "Finally, a sub analyses using linear mixed-effects models was performed on the general subscale global health status/QoL over time stratified by Na divided into quartiles.",
            "section": "Statistical analyses"
        },
        {
            "text": "all statistical tests were two-sided and considered significant if p \ue02c 0.05. ",
            "section": "Statistical analyses"
        },
        {
            "text": "all analyses were conducted using SPSS version 19.0 (Statistical Package for Social Sciences, Chicago, IL, USa). ",
            "section": "Statistical analyses",
            "entity_spans": [
                {
                    "start": 34,
                    "end": 38,
                    "type": "software",
                    "rawForm": "SPSS",
                    "resp": "#annotator12",
                    "used": true,
                    "id": "cd161a2fd6-software-0"
                },
                {
                    "start": 47,
                    "end": 51,
                    "type": "version",
                    "rawForm": "19.0",
                    "resp": "#annotator12",
                    "id": "#cd161a2fd6-software-0"
                },
                {
                    "start": 53,
                    "end": 92,
                    "type": "publisher",
                    "rawForm": "Statistical Package for Social Sciences",
                    "resp": "#curator",
                    "id": "#cd161a2fd6-software-0"
                }
            ]
        },
        {
            "text": "Missing items from multi-item scales of the EORTC QLQ-C30 and EORTC QLQ-CR38 were mean-imputed if at least half of the items from the scale were answered, according to the EORTC guideline. ",
            "section": "Statistical analyses"
        },
        {
            "text": "Missing items on the DS14 and HaDS scales were mean imputed if only one item was missing, otherwise the scale score became missing [6,19].",
            "section": "Statistical analyses",
            "ref_spans": [
                {
                    "start": 131,
                    "end": 137,
                    "type": "bibr",
                    "text": "[6,19]"
                }
            ]
        },
        {
            "text": "The questionnaire was completed by 73% (n \ue035 2625) at T1, 83% (n \ue035 1643) at T2 and 82% (n \ue035 1458) at T3. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Respondents were significantly younger (69.4 vs. 72.4; p \ue02c 0.01), more often male (55% vs. 48%; p \ue02c 0.01), were more often diagnosed with stage I disease (30% vs. 25%; p \ue035 0.02) and were more often treated with radiotherapy (31% vs. 24%; p \ue02c 0.01) compared to non-respondents. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Respondents significantly more often received radiotherapy (31% vs. 26%; p \ue02c 0.01) and surgery (99% vs.96%; p \ue035 0.01) and were more often male (55% vs. 48%; p \ue02c 0.01) compared to patients with unverifiable addresses.",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Those who completed one versus those who completed \ue024 2 questionnaires differed with respect to gender (49% vs. 43% female; p \ue02c 0.01), age (71.3 vs. 68.4 years; p \ue02c 0.001), having a partner (71% vs. 79%; p \ue02c 0.001), having a job (10% vs. 19%; p \ue02c 0.01), and radiotherapy treatment (27% vs. 32%; p \ue02c 0.01). ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "also, they more often had a lower educational level (p \ue02c 0.001), were more often diagnosed with stage IV disease (p \ue02c 0.001) and had worse scores on more than half of the subscales of the EORTC QLQ-C30 and EORTC QLQ-CR38 (global QoL, physical, role emotional and social functioning, fatigue, nausea, pain, dyspnea, appetite loss, sexual functioning, sexual enjoyment, future perspective, chemotherapy side effects and weight loss; data not shown). ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Those who completed \ue024 2 questionnaires had worse scores on the subscales gastrointestinal problems and defecation problems. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "From this point forward, only those who completed \ue024 2 questionnaires are described in the analyses.",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "at T1, 328 CRC survivors (19%) had a Type D personality (Table I). ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 56,
                    "end": 65,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "(Table I)"
                }
            ]
        },
        {
            "text": "No statistically significant differences were observed between those with and without a Type D personality in age, years since diagnosis, primary treatment and tumor type. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "However, CRC survivors with a Type D personality were significantly more often female, more often diagnosed with stage II disease, had a lower educational level and had a partner less often compared to those without a Type D personality. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Furthermore, those with Na only were younger compared to the other three groups. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Finally, those with Type D and those with Na only had more comorbid conditions compared to the other two groups.",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "HRQoL and disease-specific health status at T1, patients with Type D and Na only reported a significantly worse HRQoL and more diseasespecific symptoms compared to the other two groups except for sexual enjoyment which was only worse among those with a Type D personality, and female sexual problems which showed no differences between the groups (Table I). ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 347,
                    "end": 356,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "(Table I)"
                }
            ]
        },
        {
            "text": "Furthermore, the differences in HRQoL scores between the Type D group and the reference group, and between the Na only group and the reference group, were clinically relevant for all subscales except for nausea (Type D group) and constipation (Na only group) [20].",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 259,
                    "end": 263,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "[20]"
                }
            ]
        },
        {
            "text": "These differences in HRQoL and disease-specific health status between Type D and Na only groups versus the SI only and reference groups were quite stable across the three time points, the most relevant EORTC QLQ-C30 and EORTC QLQ-CR38 subscales with respect to survivorship [21] are presented in Figure 1. ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 296,
                    "end": 304,
                    "type": "figure",
                    "ref_id": "fig_0",
                    "text": "Figure 1"
                }
            ]
        },
        {
            "text": "However, problems with weight loss and female sexual functioning were more prevalent in the Type D group than in the other three groups at T2, and Type D patients also reported more problems regarding sexual enjoyment across all time points. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Type D patients also reported more problems with sexual functioning and male sexual functioning at T1, but not at T2 or T3 and for female sexual functioning at T2 but not T1 or T3 than patients with Na only.",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Linear mixed effects models showed that CRC survivors with a Type D personality were at a significantly increased risk of an impaired global quality of life, more insomnia, less sexual enjoyment, and a worse body image and future perspective compared to the reference group (Na-/SI-), even after controlling for sex, age, time since diagnosis, stage, chemotherapy, comorbidity, partner, education, time of questionnaire, and depression (Table II). ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 436,
                    "end": 446,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "(Table II)"
                }
            ]
        },
        {
            "text": "also, CRC survivors with a Type D personality were at a significantly increased risk of an impaired cognitive functioning (Beta -4.7, 95% CI -6.7--2.6), emotional functioning (Beta -10.3, 95% CI-11.8--8.7), more diarrhea (Beta 3.6, 95% CI 1.2-6.1), constipation (Beta 2.3, 95% CI 0.1-4.5), gastrointestinal problems (Beta 3.2, 95% CI 1.6-4.8), defecation problems (Beta 3.6, 95% CI 2.0-5.2), stoma-related problems (Beta 8.9, 95% CI 3.8-14.0), and female sexual problems (Beta 14.8, 95% CI 5.5-24.0) in comparison to the reference group. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Other important determinants of HRQoL and disease-specific symptoms were sex, age, time since diagnosis, comorbid conditions and depression (data not shown).",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Furthermore, linear mixed effects models showed that patients with Na only also reported an impaired global quality of life, more insomnia, a worse body image, and future perspective compared to the reference group but moreover, they also reported and more fatigue and pain (Table II). ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 274,
                    "end": 284,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "(Table II)"
                }
            ]
        },
        {
            "text": "additionally, those who score high on Na reported more problems with cognitive functioning (Beta 25.4, 95% CI 27.8-22.9), social functioning (Beta 22.7, 95% CI 25.1-20.3), emotional functioning (Beta 212.6, 95% CI 214.4-210.7), and more diarrhea (Beta 3.7, 95% CI 0.8-6.6), gastrointestinal problems (Beta 4.4, 95% CI 2.5-6.5), defecation problems (Beta 2.9, 95% CI 1.0-4.8), stoma-related problems (Beta 8.6, 95% CI 2.7-14.5), micturition problems (Beta 3.1, 95% CI 0.8-5.4) and financial problems (Beta 3.2, 95% CI 0.7-5.6).",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "as patients with Type D and Na only reported very similar scores on most outcomes, we performed a sub analysis on the general and overarching \"global health status/QoL\" scale over time stratified by Na divided into quartiles (Figure 2). ",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 225,
                    "end": 235,
                    "type": "figure",
                    "text": "(Figure 2)"
                }
            ]
        },
        {
            "text": "Results showed that all Na quartiles differed significantly from each other at each time point with respect to global health status/QoL, except for quartile 1 (lowest) and 2 which did not differ. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "Only those who completed two or more questionnaires were included in the analyses. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "a higher score on the EORTC QLQ-C30 and EORTC QLQ-CR38 functional scales, global QOL scale and single items (i.e. body image, sexual functioning, sexual enjoyment and future perspective) represent a higher level of function. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "For the symptom scales and single items, a higher score represents a higher level of symptoms. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "a p-Value represents the difference between the four personality groups; b Clinically relevant differences between the Type D group (Na\ue031 SI\ue031) and the reference group (Na-SI-) and between the Na only group (Na\ue031 SI-) and the reference group (Na-SI-) according the guidelines [20]; c this question was filled out by a small number of patients.",
            "section": "Sociodemographic and clinical characteristics",
            "ref_spans": [
                {
                    "start": 273,
                    "end": 277,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "[20]"
                }
            ]
        },
        {
            "text": "they reported more insomnia, diarrhea, constipation, gastrointestinal-, defecation-, stoma-related-, and female sexual problems, and a worse body image and future perspective compared to the reference group, even after controlling for sociodemographic and clinical variables. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "High Na patients reported similar poor outcomes as Type Ds. ",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "However, they also reported a lower social functioning and more fatigue, pain, micturition-and financial",
            "section": "Sociodemographic and clinical characteristics"
        },
        {
            "text": "CRC survivors with a Type D personality and those with high Na reported a significantly worse HRQoL and disease-specific health status and these differences were quite stable over time. ",
            "section": "Discussion"
        },
        {
            "text": "Furthermore, linear mixed effects models showed that Type D patients had a lower quality of life, cognitive and emotional functioning, and sexual enjoyment, and problems, while Type D individuals reported more sexual problems and less sexual enjoyment. ",
            "section": "Discussion"
        },
        {
            "text": "To our knowledge, other studies that prospectively describe the influence of Type D personality and its components on HRQoL and disease-specific health status among cancer patients are lacking. ",
            "section": "Discussion"
        },
        {
            "text": "However, a prospective study among 144 CRC patients showed that personality variables can predict a decrease in HRQoL over a one-year period [11]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 141,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "[11]"
                }
            ]
        },
        {
            "text": "Furthermore, our results confirm those of a crosssectional study on Type D personality among 124 Taiwanese CRC survivors that also reported that Type D personality was an important factor associated with QoL [22]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 208,
                    "end": 212,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "[22]"
                }
            ]
        },
        {
            "text": "Finally, prospective studies among cardiovascular patients also showed that Type D personality has a negative influence on HRQoL and disease-specific health status [23][24][25][26].",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 164,
                    "end": 168,
                    "type": "bibr",
                    "ref_id": "b33",
                    "text": "[23]"
                },
                {
                    "start": 168,
                    "end": 172,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "[24]"
                },
                {
                    "start": 172,
                    "end": 176,
                    "type": "bibr",
                    "text": "[25]"
                },
                {
                    "start": 176,
                    "end": 180,
                    "type": "bibr",
                    "text": "[26]"
                }
            ]
        },
        {
            "text": "Importantly, our study showed that the Na component of Type D was more prominent than SI in predicting worse patient-reported outcomes. ",
            "section": "Discussion"
        },
        {
            "text": "This suggests that Na should be the primary focus when evaluating personality-related differences in patientreported outcomes. ",
            "section": "Discussion"
        },
        {
            "text": "Other studies also suggested that the Na component of Type D is the key predictor of subjective health outcomes in both healthy [27] and cardiac populations [28]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 128,
                    "end": 132,
                    "type": "bibr",
                    "text": "[27]"
                },
                {
                    "start": 157,
                    "end": 161,
                    "type": "bibr",
                    "ref_id": "b40",
                    "text": "[28]"
                }
            ]
        },
        {
            "text": "The specific combination of Na and SI in the Type D construct may be more important regarding the risk of adverse cardiac events. ",
            "section": "Discussion"
        },
        {
            "text": "a recent study in 541 patients with coronary artery disease showed that Type D personality was associated with cardiac death and myocardial infarction, while patients with high Na or SI alone were not at an increased risk [29].",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 222,
                    "end": 226,
                    "type": "bibr",
                    "text": "[29]"
                }
            ]
        },
        {
            "text": "The present study has some limitations. ",
            "section": "Discussion"
        },
        {
            "text": "although we had sociodemographic and clinical information of non-respondents, it remains unknown whether they declined to participate because of poor health. ",
            "section": "Discussion"
        },
        {
            "text": "Furthermore, personality traits like neuroticism or a low sense of coherence are also known to exert influence on HRQoL and we did not take them into account. ",
            "section": "Discussion"
        },
        {
            "text": "Finally, although Type D personality is a stable construct [30], and although this is a prospective study, our analyses limit the determination of causal association between personality and patientreported outcomes as baseline data on these outcomes are unknown. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 59,
                    "end": 63,
                    "type": "bibr",
                    "text": "[30]"
                }
            ]
        },
        {
            "text": "The strengths of this study are  that we assessed HRQoL and disease-specific health status prospectively in a large population-based setting which provides information on the persistence of these constructs over time in a representative group of CRC patients in daily practice. ",
            "section": "Discussion"
        },
        {
            "text": "Type D personality and high Na were associated with poor HRQoL and disease-specific health status among survivors of CRC, even after controlling for sociodemographic and clinical variables. ",
            "section": "Discussion"
        },
        {
            "text": "By taking a patient's personality into account, this study offers a different view on personalized medicine. ",
            "section": "Discussion"
        },
        {
            "text": "Evaluating HRQoL and disease-specific health status according to personality is of great value as this informs about the disease burden and treatment-related effects directly from the patients' perspective. ",
            "section": "Discussion"
        },
        {
            "text": "This information will help clinicians to inform CRC patients about potential late side effects. ",
            "section": "Discussion"
        },
        {
            "text": "Furthermore, this can possibly lead to the development and evaluation of strategies for tailored long-term management and support for survivors on the basis of a more individualized approach, as a function of stable differences in coping with chronic medical conditions. ",
            "section": "Discussion"
        },
        {
            "text": "For example, mindfulness-based stress reduction may reduce levels of negative affectivity and social inhibition [31]. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 112,
                    "end": 116,
                    "type": "bibr",
                    "text": "[31]"
                }
            ]
        },
        {
            "text": "Paying attention to the recognition of Na seems warranted as these patients reported a worse HRQoL and disease-specific health status. ",
            "section": "Discussion"
        },
        {
            "text": "Figure 2. ",
            "section": "Discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 8,
                    "type": "figure",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "global health status/QoL over time stratified by negative affectivity. ",
            "section": "Discussion"
        },
        {
            "text": "Only those who completed two or more questionnaires were included in the analyses.",
            "section": "Discussion"
        },
        {
            "text": "We would like to thank all patients and their doctors for their participation in the study. ",
            "section": "Acknowledgments"
        },
        {
            "text": "Special thanks go to Dr. M. van Bommel, who was willing to function as an independent advisor and to answer questions of patients. ",
            "section": "Acknowledgments"
        },
        {
            "text": "In addition, we want to thank the following hospitals for their cooperation: amphia Hospital, Breda; Bernhoven Hospital, Veghel and Oss; Catharina Hospital, Eindhoven; Elkerliek Hospital, Helmond; Jeroen Bosch Hospital, 's Hertogenbosch; Maxima Medical Centre, Eindhoven and Veldhoven; Sint anna Hospital, geldrop; St. Elisabeth Hospital, Tilburg; Twee Steden Hospital, Tilburg and Waalwijk; VieCury Hospital, Venlo and Venray. ",
            "section": "Acknowledgments"
        },
        {
            "text": "The present research was supported by a VENI grant (#451-10-041) from the Netherlands Organization for Scientific Research (The Hague, The Netherlands) awarded to Floortje Mols.",
            "section": "Acknowledgments"
        },
        {
            "text": "The authors report no conflicts of interest. ",
            "section": "Declaration of interest:"
        },
        {
            "text": "The authors alone are responsible for the content and writing of the paper.",
            "section": "Declaration of interest:"
        }
    ]
}